-
1
-
-
1642579678
-
Complementary and alternative therapies for cancer
-
February 1
-
Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004(February 1);9(1):80-89.
-
(2004)
Oncologist
, vol.9
, Issue.1
, pp. 80-89
-
-
Cassileth, B.R.1
Deng, G.2
-
3
-
-
34147101252
-
Complementary cancer therapy: A systematic review of prospective clinical trials on anthroposophic mistletoe extracts
-
Kienle GS, Kiene H. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res. 2007;12:1-17.
-
(2007)
Eur J Med Res
, vol.12
, pp. 1-17
-
-
Kienle, G.S.1
Kiene, H.2
-
4
-
-
0141449180
-
Über die Zusatzbehandlung beim weiblichen Genitalkarzinom
-
Majewski A, Bentele W. Über die Zusatzbehandlung beim weiblichen Genitalkarzinom. Zentralbl Gynäkol. 1963;85 (20):696-700.
-
(1963)
Zentralbl Gynäkol
, vol.85
, Issue.20
, pp. 696-700
-
-
Majewski, A.1
Bentele, W.2
-
5
-
-
0035004688
-
Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: Prospective nonrandomized and randomized matched-pairs studies nested within a cohort study
-
Grossarth-Maticek R, Kiene H, Baumgartner S, Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pairs studies nested within a cohort study. Altern Ther Health Med. 2001;7(3):57-78.
-
(2001)
Altern Ther Health Med
, vol.7
, Issue.3
, pp. 57-78
-
-
Grossarth-Maticek, R.1
Kiene, H.2
Baumgartner, S.3
Ziegler, R.4
-
6
-
-
33750388867
-
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador)
-
Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador). Forsch Komplementärmed. 2006;13:285-292.
-
(2006)
Forsch Komplementärmed
, vol.13
, pp. 285-292
-
-
Grossarth-Maticek, R.1
Ziegler, R.2
-
7
-
-
33747242669
-
Circular instead of hierarchical: Methodological principles for the evaluation of complex interventions
-
Walach H, Falkenberg T, Fonnebo V, Lewith G, Jonas WB. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions. BMC Med Res Methodol. 2006;6(29).
-
(2006)
BMC Med Res Methodol
, vol.6
, Issue.29
-
-
Walach, H.1
Falkenberg, T.2
Fonnebo, V.3
Lewith, G.4
Jonas, W.B.5
-
8
-
-
33845518673
-
Randomised and non-randomised prospective controlled cohort studies in matched pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): A re-analysis
-
Grossarth-Maticek R, Ziegler R. Randomised and non-randomised prospective controlled cohort studies in matched pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): A re-analysis. Europ J Med Res. 2006;11(11):485-495.
-
(2006)
Europ J Med Res
, vol.11
, Issue.11
, pp. 485-495
-
-
Grossarth-Maticek, R.1
Ziegler, R.2
-
11
-
-
0002302876
-
Psychotherapy research in oncology
-
Steptoe A, Matthews A, eds, New York: Academic Press;
-
Grossarth-Maticek R, Schmidt P, Vetter H, Arndt S. Psychotherapy research in oncology. In: Steptoe A, Matthews A, eds. Health Care and Human Behavior. New York: Academic Press; 1984. p. 325-341.
-
(1984)
Health Care and Human Behavior
, pp. 325-341
-
-
Grossarth-Maticek, R.1
Schmidt, P.2
Vetter, H.3
Arndt, S.4
-
12
-
-
0000733019
-
Self-regulation and mortality from cancer, coronary heart disease, and other causes: A prospective study
-
Grossarth-Maticek R, Eysenck HJ. Self-regulation and mortality from cancer, coronary heart disease, and other causes: a prospective study. Pers Individ Diff. 1995;19(6):781-795.
-
(1995)
Pers Individ Diff
, vol.19
, Issue.6
, pp. 781-795
-
-
Grossarth-Maticek, R.1
Eysenck, H.J.2
-
14
-
-
0033970588
-
Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment
-
Grossarth-Maticek R, Eysenck H-J, Boyle GJ, Heeb J, Costa SD, Diel IJ. Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment. J Clin Psych. 2000;56(1):33-50.
-
(2000)
J Clin Psych
, vol.56
, Issue.1
, pp. 33-50
-
-
Grossarth-Maticek, R.1
Eysenck, H.-J.2
Boyle, G.J.3
Heeb, J.4
Costa, S.D.5
Diel, I.J.6
-
16
-
-
0029067082
-
Method of test administration as a factor in text validity: The use of a personality questionnnaire in the prediction of cancer and coronary heart disease
-
Grossarth-Maticek R, Eysenck HJ, Boyle GJ. Method of test administration as a factor in text validity: the use of a personality questionnnaire in the prediction of cancer and coronary heart disease. Behav Res Ther. 1995;33(6):705-710.
-
(1995)
Behav Res Ther
, vol.33
, Issue.6
, pp. 705-710
-
-
Grossarth-Maticek, R.1
Eysenck, H.J.2
Boyle, G.J.3
-
18
-
-
0001586397
-
Biological and pharmacological properties of Viscum album L
-
Büssing A, ed, Amsterdam: Harwood Academic Publisher;
-
Bussing A. Biological and pharmacological properties of Viscum album L. In: Büssing A, ed. Mistletoe: The Genus Viscum. Amsterdam: Harwood Academic Publisher; 2000. p. 123-182.
-
(2000)
Mistletoe: The Genus Viscum
, pp. 123-182
-
-
Bussing, A.1
-
19
-
-
3442902177
-
Mistel (Viscum album) - anthroposophischer und phytotherapeutischer Ansatz
-
Münstedt K, ed, Landsberg: Ecomed;
-
Bussing A. Mistel (Viscum album) - anthroposophischer und phytotherapeutischer Ansatz. In: Münstedt K, ed. Ratgeber Unkonventionelle Methoden. Landsberg: Ecomed; 2003. p. 184-199.
-
(2003)
Ratgeber Unkonventionelle Methoden
, pp. 184-199
-
-
Bussing, A.1
-
20
-
-
3442880810
-
Keine Stimulation in-vitro-kultivierter Tumorzellen durch Mistellektin
-
Büssing A, Schietzel D, Schietzel M, Schink M, Stein GM. Keine Stimulation in-vitro-kultivierter Tumorzellen durch Mistellektin. Dtsch Z Onkol. 2004;36(1):33-70.
-
(2004)
Dtsch Z Onkol
, vol.36
, Issue.1
, pp. 33-70
-
-
Büssing, A.1
Schietzel, D.2
Schietzel, M.3
Schink, M.4
Stein, G.M.5
-
21
-
-
35948964963
-
-
Büssing A. Pharmakologische Wirkungen von Mistelextrakten. In: Fintelmann V, ed. Onkologie auf anthroposophischer Grundlage. Stuttgart: Mayer (1. Lieferung); 2002. Section 3.2.4.1.
-
Büssing A. Pharmakologische Wirkungen von Mistelextrakten. In: Fintelmann V, ed. Onkologie auf anthroposophischer Grundlage. Stuttgart: Mayer (1. Lieferung); 2002. Section 3.2.4.1.
-
-
-
-
22
-
-
33748663282
-
Immune modulation using mistletoe (Viscum album L.) extracts Iscador
-
Büssing A. Immune modulation using mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung (Drug Research). 2006;56(6a):508-515.
-
(2006)
Arzneimittel-Forschung (Drug Research)
, vol.56
, Issue.6 A
, pp. 508-515
-
-
Büssing, A.1
-
23
-
-
33748641369
-
Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador
-
Kelter G, Fiebig HH. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung (Drug Research). 2006;56(6a):435-440.
-
(2006)
Arzneimittel-Forschung (Drug Research)
, vol.56
, Issue.6 A
, pp. 435-440
-
-
Kelter, G.1
Fiebig, H.H.2
-
24
-
-
33748665010
-
Preclinical investigations with mistletoe (Viscum album L.) extracts Iscador
-
Maldacker J. Preclinical investigations with mistletoe (Viscum album L.) extracts Iscador. Arzneimittel-Forschung (Drug Research). 2006;56(64):497-507.
-
(2006)
Arzneimittel-Forschung (Drug Research)
, vol.56
, Issue.64
, pp. 497-507
-
-
Maldacker, J.1
-
26
-
-
0035906308
-
The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
-
Moher D, Schulz KF, Altman DG. The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Med Assoc. 2001;285:1987-1991.
-
(2001)
J Am Med Assoc
, vol.285
, pp. 1987-1991
-
-
Moher, D.1
Schulz, K.F.2
Altman, D.G.3
-
27
-
-
4644367501
-
Guidelines for reporting non-randomised studies
-
Reeves BC, Gaus W. Guidelines for reporting non-randomised studies. Forsch Komplementärmed. 2004;11 (Suppl 1):46-52.
-
(2004)
Forsch Komplementärmed
, vol.11
, Issue.SUPPL. 1
, pp. 46-52
-
-
Reeves, B.C.1
Gaus, W.2
-
33
-
-
35948942826
-
Systemische Primätherapie
-
Schmalfeldt B, ed, 7th ed. München: Zuckschwerdt;
-
Burges A, Janni W, Kümper C, Lutz L, Petrides P, Pildner von Steinburg S, et al. Systemische Primätherapie. In: Schmalfeldt B, ed. Manual Maligne Ovarialtumoren: Empfehlungen zur Diagnostik, Therapie und Nachsorge. 7th ed. München: Zuckschwerdt; 2004:44-51.
-
(2004)
Manual Maligne Ovarialtumoren: Empfehlungen zur Diagnostik, Therapie und Nachsorge
, pp. 44-51
-
-
Burges, A.1
Janni, W.2
Kümper, C.3
Lutz, L.4
Petrides, P.5
Pildner von Steinburg, S.6
-
34
-
-
0000958776
-
Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma
-
DeVita Jr VT, Hellman S, Rosenberg SA, eds, 6th ed. Philadelphia: Lippincott Williams & Wilkins;
-
Ozols RF, Schwartz PE, Eifel PJ. Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma. In: DeVita Jr VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology (Section 365). 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1597-1632.
-
(2001)
Cancer: Principles & Practice of Oncology (Section 365)
, pp. 1597-1632
-
-
Ozols, R.F.1
Schwartz, P.E.2
Eifel, P.J.3
-
35
-
-
4644347319
-
Reasons for caution when evaluating health care interventions using non-randomised study designs
-
Reeves BC. Reasons for caution when evaluating health care interventions using non-randomised study designs. Forsch Komplementärmed. 2004;11(Suppl 1):40-45.
-
(2004)
Forsch Komplementärmed
, vol.11
, Issue.SUPPL. 1
, pp. 40-45
-
-
Reeves, B.C.1
-
36
-
-
1442350530
-
Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial
-
Piao BK, Wang YX, xie GR, Mansmann U, Matthes H, Beuth J, et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res. 2004;24(1):303-310.
-
(2004)
Anticancer Res
, vol.24
, Issue.1
, pp. 303-310
-
-
Piao, B.K.1
Wang, Y.X.2
xie, G.R.3
Mansmann, U.4
Matthes, H.5
Beuth, J.6
-
37
-
-
0242309722
-
Mistletoe in cancer: A systematic review on controlled clinical trials
-
Kienle GS, Berrino R, Büssing A, Portalupi E, Rosenzweig S, Kiene H. Mistletoe in cancer: A systematic review on controlled clinical trials. Eur J Med Res. 2003;8:109-119.
-
(2003)
Eur J Med Res
, vol.8
, pp. 109-119
-
-
Kienle, G.S.1
Berrino, R.2
Büssing, A.3
Portalupi, E.4
Rosenzweig, S.5
Kiene, H.6
-
38
-
-
0028191359
-
Mistletoe treatment for cancer: Review of controlled trials in humans
-
Kleijnen J, Knipschild P. Mistletoe treatment for cancer: review of controlled trials in humans. Phytomedicine. 1994;1:255-260.
-
(1994)
Phytomedicine
, vol.1
, pp. 255-260
-
-
Kleijnen, J.1
Knipschild, P.2
-
39
-
-
0018741234
-
Welche Erfolgsaussichten bietet die Iscador-Therapie beim fortgeschrittenen Ovarialkarzinom?
-
Hassauer W, Gutsch J, Burkhardt R. Welche Erfolgsaussichten bietet die Iscador-Therapie beim fortgeschrittenen Ovarialkarzinom? Onkologie. 1979;2(1):28-36.
-
(1979)
Onkologie
, vol.2
, Issue.1
, pp. 28-36
-
-
Hassauer, W.1
Gutsch, J.2
Burkhardt, R.3
-
40
-
-
0020326045
-
Die Iscadortherapie beim Ovarialkarzinom
-
Leroi R, Hajto T. Die Iscadortherapie beim Ovarialkarzinom. Krebsgeschehen. 1982;14(2):38-44.
-
(1982)
Krebsgeschehen
, vol.14
, Issue.2
, pp. 38-44
-
-
Leroi, R.1
Hajto, T.2
-
41
-
-
35948959136
-
-
Schreiber K, Stumpf C. Iscador in der postoperativen Therapie des Ovarialkarzinoms: Ergebnisse 24jähriger Therapie. Erfahrungsheilkunde. 1984;33(6):349-358.
-
Schreiber K, Stumpf C. Iscador in der postoperativen Therapie des Ovarialkarzinoms: Ergebnisse 24jähriger Therapie. Erfahrungsheilkunde. 1984;33(6):349-358.
-
-
-
-
42
-
-
33750416140
-
Klinische Studien zur Misteltherapie der Krebserkrankung - Eine Übersicht
-
Kienle GS, Kiene H. Klinische Studien zur Misteltherapie der Krebserkrankung - Eine Übersicht. Erfahrungsheilkunde. 2004;53:193-209.
-
(2004)
Erfahrungsheilkunde
, vol.53
, pp. 193-209
-
-
Kienle, G.S.1
Kiene, H.2
-
43
-
-
0001484704
-
Klinische Studien zur Misteltherapie karzinomatöser Erkrangungen. Eine Übersicht
-
347-353
-
Kiene H. Klinische Studien zur Misteltherapie karzinomatöser Erkrangungen. Eine Übersicht, therapeutikon. 1989;3(6):347-353.
-
(1989)
therapeutikon
, vol.3
, Issue.6
-
-
Kiene, H.1
-
44
-
-
0242309731
-
Adverse effects during therapy with mistletoe extracts
-
Bussing A, ed, Amsterdam: Harwood Academic Publishers;
-
Stein GM, Berg PA. Adverse effects during therapy with mistletoe extracts. In: Bussing A, ed. Mistletoe - The Genus Viscum. Amsterdam: Harwood Academic Publishers; 2000:195-208.
-
(2000)
Mistletoe - The Genus Viscum
, pp. 195-208
-
-
Stein, G.M.1
Berg, P.A.2
-
45
-
-
35948971903
-
Unerwünschte Wirkungen der Misteltherapie bei Tumorpatienten - Eine systematische Übersicht
-
Scheer R, Bauer R, Becker H, Fintelmann V, Kemper FH, Schilcher H, eds, Essen: KVC Verlag;
-
Saller R, Kramer S, Iten F, Melzer J. Unerwünschte Wirkungen der Misteltherapie bei Tumorpatienten - Eine systematische Übersicht. In: Scheer R, Bauer R, Becker H, Fintelmann V, Kemper FH, Schilcher H, eds. Fortschritte in der Misteltherapie: Aktueller Stand der Forschung und klinische Anwendung. Essen: KVC Verlag; 2005:367-403.
-
(2005)
Fortschritte in der Misteltherapie: Aktueller Stand der Forschung und klinische Anwendung
, pp. 367-403
-
-
Saller, R.1
Kramer, S.2
Iten, F.3
Melzer, J.4
-
46
-
-
35948954097
-
-
Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichen Diskussion - Teil 1. PraxisMagazin. 2005;21(12/2004-1/2005):6-14.
-
Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichen Diskussion - Teil 1. PraxisMagazin. 2005;21(12/2004-1/2005):6-14.
-
-
-
-
47
-
-
35948939094
-
-
Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichenDiskussion-Teil 2. PraxisMagazin.2005;22(2/2005):6-17.
-
Saller R, Reichling J, Melzer J. Die Misteltherapie. Erwünschte und unerwünschte Wirkungen in der wissenschaftlichenDiskussion-Teil 2. PraxisMagazin.2005;22(2/2005):6-17.
-
-
-
-
48
-
-
4344630940
-
-
Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B. Wirksamkeit und Sicherheit der komplementären Langzeitbehandlung mit einem standardisierten Extrakt aus Europäischer Mistel (Viscum album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom. Ergebnisse einer multizentrischen, komparativen, retrolektiven, epidemiologischen Kohortenstudie in Deutschland und der Schweiz. Arzneimittel-Forschung (Drug Research). 2004;54(8):456-466.
-
Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B. Wirksamkeit und Sicherheit der komplementären Langzeitbehandlung mit einem standardisierten Extrakt aus Europäischer Mistel (Viscum album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom. Ergebnisse einer multizentrischen, komparativen, retrolektiven, epidemiologischen Kohortenstudie in Deutschland und der Schweiz. Arzneimittel-Forschung (Drug Research). 2004;54(8):456-466.
-
-
-
-
49
-
-
12944320296
-
Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract: Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland
-
Augustin M, Bock PR, Hanisch J, Karasmann M, Schneider B. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract: Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittel-Forschung (Drug Research). 2005;55(1):38-49.
-
(2005)
Arzneimittel-Forschung (Drug Research)
, vol.55
, Issue.1
, pp. 38-49
-
-
Augustin, M.1
Bock, P.R.2
Hanisch, J.3
Karasmann, M.4
Schneider, B.5
|